Clinical trial
Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events…
NCT00408057 · Canadian Heart Research Centre, Other · Completed
Key facts
| NCT number | NCT00408057 |
|---|---|
| Title | Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE ) |
| Official title | Quality Enhancement Research Initiative (QERI) in the Dyslipidemia Management Strategy Involving Ezetimibe With Statin in High Risk Patients Who Have Not Achieved Recommended LDL Targets |
| Acronym | GUIDE |
| Lead sponsor | Canadian Heart Research Centre, Other |
| Collaborators | Merck Frosst Canada Ltd. Industry Schering-Plough |
| Status | Completed |
| Study type | Observational |
| Conditions | Cardiovascular Diseases |
| Intervention type | Other |
| Interventions | no intervention |
| Enrollment | 2,500 |
| Start date | Dec 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Dec 6, 2006 |
| Last update posted | May 14, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: